| Name | Title | Contact Details |
|---|
Sandra Heath and Associates is a Cleveland, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Buckeye Home Health Care is a Medicare Certified agency that provides comprehensive healthcare services by a variety of healthcare professionals in the comfort of your own home.
TeamHealth Medical Call Center is a Knoxville, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MedData is a leading national provider of technology-enabled healthcare services designed to improve financial outcomes for hospitals by enhancing the patient experience and expanding their access to healthcare. The MedData suite of solutions includes a range of patient access & communications, revenue cycle management, and consulting & analytics services, including full service billing & coding, patient balances, eligibility & disability, third party liability and other complex A/R services, and mobile-first engagement and communication software for patients and providers. MedData has built this national presence by becoming experts at the state level. To date, we have handled billing for more than 200 million patients at our growing network of more than 2,000 hospital sites nationwide. For more than 36 years, MedData has solidified its leadership position by providing innovative solutions to the medical community and serving millions of patients across numerous medical specialties.
Cleveland BioLabs, Inc. (NASDAQ: CBLI) is an innovative bio pharmaceutical company developing novel approaches to activate the immune system and address serious medical needs. Our proprietary platform of toll-like immune receptor activators has applications in radiation mitigation, oncology immunotherapy, and vaccines. We combine our proven scientific expertise and our depth of knowledge about our products’ mechanisms of action into a passion for developing drugs to save lives. Our proprietary drug candidates act via unique mechanisms that are designed to kill cancer and protect healthy cells. Our most advanced product candidate is entolimod, which we are developing as a radiation countermeasure and an immunotherapy for oncology and other indications. We have additional pipeline product candidates in various stages of development.